Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Molecular and Cellular Biology
|
July 22, 2009
mTORC1 hyperactivity inhibits serum deprivation-induced apoptosis via increased hexokinase II and GLUT1 expression, sustained Mcl-1 expression, and glycogen synthase kinase 3beta inhibition
Prashanth T Bhaskar, Veronique Nogueira, Krushna C Patra, et al.
World Journal of Hepatology
|
April 5, 2021
BIR repeat-containing ubiquitin conjugating enzyme (BRUCE) regulation of β-catenin signaling in the progression of drug-induced hepatic fibrosis and carcinogenesis
Chrystelle L Vilfranc, Li-Xiao Che, Krushna C Patra, et al.
Nature Communications
|
February 2, 2018
Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin
Dannielle DeWaal, Veronique Nogueira, Alexander R Terry, et al.
Nature Communications
|
June 28, 2018
Author Correction: Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin
Dannielle DeWaal, Veronique Nogueira, Alexander R Terry, et al.
Cancer Research
|
April 24, 2013
DDB2 suppresses epithelial-to-mesenchymal transition in colon cancer
Nilotpal Roy, Prashant V Bommi, Uppoor G Bhat, et al.
Nature Communications
|
February 17, 2022
A non-catalytic scaffolding activity of hexokinase 2 contributes to EMT and metastasis
Catherine S Blaha, Gopalakrishnan Ramakrishnan, Sang-Min Jeon, et al.
Cancer Cell
|
August 6, 2013
Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer
Krushna C Patra, Qi Wang, Prashanth T Bhaskar, et al.
Nature Cell Biology
|
June 27, 2018
Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism
Krushna C Patra, Yasutaka Kato, Yusuke Mizukami, et al.
Biorxiv : the Preprint Server for Biology
|
January 31, 2024
Copper drives remodeling of metabolic state and progression of clear cell renal cell carcinoma
Megan E Bischoff, Behrouz Shamsaei, Juechen Yang, et al.
Cancer Discovery
|
September 26, 2024
DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming
Ilaria Gritti, Jinkai Wan, Vajira Weeresekara, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Molecular and Cellular Biology
|
July 22, 2009
mTORC1 hyperactivity inhibits serum deprivation-induced apoptosis via increased hexokinase II and GLUT1 expression, sustained Mcl-1 expression, and glycogen synthase kinase 3beta inhibition
Prashanth T Bhaskar, Veronique Nogueira, Krushna C Patra, et al.
World Journal of Hepatology
|
April 5, 2021
BIR repeat-containing ubiquitin conjugating enzyme (BRUCE) regulation of β-catenin signaling in the progression of drug-induced hepatic fibrosis and carcinogenesis
Chrystelle L Vilfranc, Li-Xiao Che, Krushna C Patra, et al.
Nature Communications
|
February 2, 2018
Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin
Dannielle DeWaal, Veronique Nogueira, Alexander R Terry, et al.
Nature Communications
|
June 28, 2018
Author Correction: Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin
Dannielle DeWaal, Veronique Nogueira, Alexander R Terry, et al.
Cancer Research
|
April 24, 2013
DDB2 suppresses epithelial-to-mesenchymal transition in colon cancer
Nilotpal Roy, Prashant V Bommi, Uppoor G Bhat, et al.
Nature Communications
|
February 17, 2022
A non-catalytic scaffolding activity of hexokinase 2 contributes to EMT and metastasis
Catherine S Blaha, Gopalakrishnan Ramakrishnan, Sang-Min Jeon, et al.
Cancer Cell
|
August 6, 2013
Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer
Krushna C Patra, Qi Wang, Prashanth T Bhaskar, et al.
Nature Cell Biology
|
June 27, 2018
Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism
Krushna C Patra, Yasutaka Kato, Yusuke Mizukami, et al.
Biorxiv : the Preprint Server for Biology
|
January 31, 2024
Copper drives remodeling of metabolic state and progression of clear cell renal cell carcinoma
Megan E Bischoff, Behrouz Shamsaei, Juechen Yang, et al.
Cancer Discovery
|
September 26, 2024
DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming
Ilaria Gritti, Jinkai Wan, Vajira Weeresekara, et al.
Page
of 3